Results 251 to 260 of about 717,640 (312)

Metal nanostructure‐coupled label‐free localized surface plasmon resonance biosensors for rapid and sensitive disease diagnosis

BMEMat, EarlyView.
LSPR biosensing enables rapid, sensitive, and low‐sample‐volume detection of biomarkers, with broad applications in diagnosing cancer, infectious, and chronic diseases. Advances in nanostructure design, micro/nanofabrication, and microfluidic integration have expanded the potential of LSPR sensors in biomedical diagnostics.
Zhaoxin Geng, Yunfei Sha, Jiongyan Yang, Hongru Yang, Xiao Liang   +4 more
wiley   +1 more source

Progression to Dementia in Very Late-Onset Schizophrenia-Like Psychosis Stratified by Alzheimer's Disease and Lewy Body Disease Biomarkers: A Retrospective Cohort Study. [PDF]

Psychogeriatrics
Satake Y, Kanemoto H, Taomoto D, Takeda K, Katakami S, Kobayashi M, Matsunaga K, Isohashi K, Suehiro T, Yoshiyama K, Ikeda M.   +10 more
europepmc   +1 more source

Individuals with dementia and populations with dementia

Cerebral Circulation - Cognition and Behavior
openaire   +3 more sources

Leveraging the Neurology Revolution to Enable Supermentia and Enhance Cognitive Evolution and Human Development

Brain Health, EarlyView.
ABSTRACT The level of human cognition has enabled advancements in technologies that enable planetary and space exploration with discoveries and innovations. The understanding of human cognition and the evolution of cognition in other species, alongside advances in neuroscience, serve as catalysts for the neurology revolution aimed at enhancing human ...
Paul Olowoyo, Vladimir Hachinski, Mayowa Owolabi   +2 more
wiley   +1 more source

Measuring what matters: evaluating the psychometric properties of goal attainment scaling in a psychosocial dementia trial. [PDF]

Age Ageing
Budgett J, Demnitz-King H, Sommerlad A, Kupeli N, Vickerstaff V, Cooper C.   +5 more
europepmc   +1 more source

The Global, Regional, and National Burden of Young‐Onset Dementia: An Updated Analysis of the Global Burden of Disease Study 2021

Brain Health, EarlyView.
ABSTRACT Young‐onset dementia (YOD), defined as dementia with onset between 40 and 65 years of age, is an emerging global health concern associated with substantial healthcare and socioeconomic burdens. Using data from the Global Burden of Disease Study 2021, this population‐based study analyzed trends in the prevalence, death rates, and disability ...
Yang Zhao, Tai‐Yi Sun, Rui Zhang, Yu‐Hui Liu, Yan‐Jiang Wang   +4 more
wiley   +1 more source

Epidemiology as a Cornerstone of Brain Health: From Measuring Burden to Prevention, Equity and Policy

Brain Health, EarlyView.
Epidemiology turns brain‐health evidence into action through six linked stages: characterise burden, map inequalities, identify determinants, evaluate interventions, assess implementation and value and translate evidence into policy, while maintaining data quality, equity, life‐course perspectives and stakeholder involvement.
Pierre‐Marie Preux, Eyram Maria Concheta Tchibozo   +1 more
wiley   +1 more source

Development and effectiveness of a user-centered mobile application for informal caregivers of people living with dementia: randomized controlled trial. [PDF]

BMC Geriatr
Yüceer B, Cinar FI, Naharci MI, Kadi B.
europepmc   +1 more source

Validation of the Quick Dementia Rating System (QDRS): diagnostic properties and cutoff values. [PDF]

Dement Neuropsychol
Senger JE, Kochhann R, Arnold D, de Bastiani MA, Detogni A, Bruscato NM, Moriguchi EH, Senger J, Fuhr AV, Palmeira ALR, Zimmer ER, Nasi LA, Martins SCO, Borelli WV.   +13 more
europepmc   +1 more source